Oncologic Imaging Program (OIP)

Program Co-Leaders

• Mark Anastasio, PhD
• Farrokh Dehdashti, MD
• Daniel Thorek, PhD

Overview of the Program

The Oncologic Imaging Program (OIP) develops novel imaging agents and innovative methods for radionuclide, MR, ultrasound, optical, and hybrid imaging technologies, including photoacoustic imaging and theranostics. Application of artificial intelligence and informatics platforms to solve advanced oncologic imaging challenges demonstrates the evolving nature of OIP. OIP’s major goals are to facilitate new research initiatives, expand ongoing collaborations, mentor junior faculty, train students and fellows, and develop new methods to solve fundamental and clinical cancer imaging needs. These goals will be achieved through intra- and interprogrammatic activities and external partnerships. OIP’s highest priorities include developing imaging agents and technologies for detecting, diagnosing, and treating cancer, and expanding our knowledge of animal models used for basic cancer research.

Aims of the OIP

OIP activities will pursue three specific aims.

1. Develop new translational technologies to accelerate cancer detection and diagnosis, assess tumor biology, and guide and monitor response to therapy.
2. Develop and translate theranostic strategies, image-guided and radiopharmaceutical therapy, to improve patient care and outcomes.
3. Investigate computational imaging and artificial intelligence technologies to enable predictive oncology and provide tools to support clinical decision-making strategies.